Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q2 2026 · 10-Q
Revenue$28.14M$28.14M+9.0% vs Q2 2025 Net Income-$452.86K-$452.86KN/M vs Q2 2025 EPS Diluted-$0.05-$0.05N/M vs Q2 2025 Gross Profit$26,155,410+9.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$2,038,472−23.5% Free Cash Flowderived$2,033,192+125.2% Margins · derivedGross margin93.0%+0.5 pt vs Q2 2025
Operating margin6.3%−3.3 pt vs Q2 2025
Net margin-1.6%+6.2 pt vs Q2 2025
ended Jun 30, 2026 · filed Aug 11, 2026 · 42 d after period end